全文获取类型
收费全文 | 165篇 |
免费 | 17篇 |
国内免费 | 1篇 |
专业分类
儿科学 | 2篇 |
妇产科学 | 3篇 |
基础医学 | 19篇 |
口腔科学 | 3篇 |
临床医学 | 22篇 |
内科学 | 34篇 |
神经病学 | 4篇 |
特种医学 | 10篇 |
外科学 | 7篇 |
综合类 | 3篇 |
预防医学 | 14篇 |
药学 | 9篇 |
中国医学 | 3篇 |
肿瘤学 | 50篇 |
出版年
2018年 | 4篇 |
2017年 | 1篇 |
2016年 | 4篇 |
2015年 | 7篇 |
2014年 | 9篇 |
2013年 | 10篇 |
2012年 | 10篇 |
2011年 | 9篇 |
2010年 | 11篇 |
2009年 | 8篇 |
2008年 | 9篇 |
2007年 | 17篇 |
2006年 | 13篇 |
2005年 | 3篇 |
2004年 | 2篇 |
2003年 | 2篇 |
2002年 | 6篇 |
2001年 | 3篇 |
2000年 | 5篇 |
1999年 | 5篇 |
1998年 | 4篇 |
1997年 | 7篇 |
1996年 | 6篇 |
1995年 | 5篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1992年 | 1篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1989年 | 4篇 |
1986年 | 2篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1978年 | 1篇 |
1974年 | 1篇 |
排序方式: 共有183条查询结果,搜索用时 35 毫秒
81.
Buist NR Glenn B Vugrek O Wagner C Stabler S Allen RH Pogribny I Schulze A Zeisel SH Barić I Mudd SH 《Journal of inherited metabolic disease》2006,29(4):538-545
This paper reports the third proven human case of deficient S-adenosylhomocysteine (AdoHcy) hydrolase activity. The patient is similar to the only two previously reported cases with this
disorder in having severe myopathy, developmental delay, elevated serum creatine kinase (CK) concentrations, and hypermethioninaemia.
Although he has been followed from infancy, the basic enzyme deficiency was established only at age 26 years. The diagnosis
was based on markedly elevated plasma concentrations of both AdoHcy and S-adenosylmethionine, some 20% of the mean control activity of AdoHcy hydrolase activity in haemolysates of his red-blood cells,
and two missense mutations in his gene encoding AdoHcy hydrolase. He had low values of erythrocyte phosphatidylcholine and
plasma free choline and marginally elevated excretion of guanidinoacetate, suggesting that the elevated AdoHcy may have been
inhibiting methylation of phosphatidylethanolamine and guanidinoacetate. His leukocyte DNA was globally more methylated than
the DNA's of his parents or the mean extent of methylation measured in age-matched control subjects.
Communicating author: Mike Gibson
Competing interests: None declared 相似文献
82.
IP Kosmas K Zikopoulos I Georgiou E Paraskevaidis C Blockeel H Tournaye J Van der Elst P Devroey 《Reproductive biomedicine online》2009,18(5):619-630
Human chorionic gonadotrophin (HCG) may substitute FSH to complete follicular growth in IVF cycles. This may be useful in the prevention of ovarian hyperstimulation syndrome. Relevant studies were identified on Medline. To evaluate outcomes, a meta-analysis of low-dose HCG-supplemented IVF cycles versus non-supplemented ones was performed with data from 435 patients undergoing IVF who were administered low-dose HCG in various agonist and antagonist protocols and from 597 conservatively treated patients who served, as control subjects. Using these published data, a decision analysis evaluated four different management strategies. Effectiveness and economic outcomes were assessed by FSH consumption, clinical pregnancy and incremental cost-effectiveness ratios. Clinical pregnancy and ovarian hyperstimulation were the main outcome measures. Nine trials published in 2002–2007 were included. From the prospective studies, in the gonadotrophin-releasing hormone antagonist group, a trend for significance in clinical pregnancy rate was evident (odds ratio [OR], 1.54; 95% confidence interval [CI], 0.98–2.42). Ovarian hyperstimulation was less significant in the antagonist low-dose HCG protocol compared with the non-supplemented agonist protocol (OR 0.30; 95% CI 0.09–0.96). Less FSH was consumed in the low-dose HCG group but this difference was not statistically significant. Low-dose HCG supplementation may improve pregnancy rates in antagonist protocols. Overall, low-dose HCG-supplemented protocols are a cost-effective strategy. 相似文献
83.
84.
85.
EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON NEUTROPHIL CHEMOTAXIS--AN IN VITRO AND IN VIVO STUDY 总被引:1,自引:0,他引:1
IP MARY; LOMAS D. A.; SHAW JEAN; BURNETT D.; STOCKLEY R. A. 《Rheumatology (Oxford, England)》1990,29(5):363-367
We have studied the effects of the two non-steroidal anti-inflammatorydrugs (NSAIDs), nabumetone and indomethacin, on neutrophil chemotaxisin vitro and in vivo. When used in therapeutic concentrationsin vitro, neither agent had any effect on the chemotactic responseof neutrophils isolated from healthy volunteers. This was truefor the three chemotactic agents studied: FMLP, zymosan activatedserum and purulent sputum. Nabumetone and indomethacin decreasedneutrophil chemotaxis over a period of 2 weeks in 12 normalsubjects in vivo. The average chemotactic response to 108mol/1 FMLP for all 12 during the control period was 42.1 ±6.1 cells per high power field and this fell to 26.1 ±4.9 (P>0.025) after 7 days and to 15.6 ± 2.5 (P>0.005)after 14 days. The results were similar for both drugs analysedindependently. The results suggest that NSAIDs have no effect on the chemotacticresponse of mature cells in vitro, but suppress chemotaxis progressivelywhen given in vivo. This may be explained by an effect of NSAIDson maturing cells prior to release into the circulation KEY WORDS: Polymorphonuclear cells, Chemotaxis, Nabumetone, Indomethacin 相似文献
86.
RANJAN K. THAKUR JOHN H. IP DAVENDRA MEHTA JIA Y. JUNG ALONSO COLLAR JORGE CAMUNAS J. ANTHONY GOMES 《Pacing and clinical electrophysiology : PACE》1995,18(1):159-162
A nonthoracotomy surgical approach using an endocardial electrode and combined implantation of a subcutaneous patch and the implantable cardioverter defibrillator (ICD) generator in a Subpectoral pocket has been described. We report the long-term follow-up results in patients undergoing implantation using this approach. The patient population consisted of 28 patients (22 men and 6 women) with a mean age of 59 ± 12 years. The underlying heart disease consisted of coronary artery disease in 20 patients and dilated cardiomyopathy in 8 patients. Sustained ventricular tachycardia was the mode of presentation in 16 patients and sudden cardiac death in 12 patients. The mean left ventricular ejection fraction was 31%± 6%. The lead system consisted of an 8 French bipolar passive fixation rate sensing lead positioned at the right ventricular apex, an 11 French spring coil electrode positioned at the superior vena cava-right atrial junction (surface area 700 mm2), and submuscular placement of a large patch (surface area 28 cm2) on the anterolateral chest wall near the cardiac apex via a submammary incision. A defibrillation threshold of ≤ 15 joules (J) was required for implantation. This criterion was not satisfied in five patients; thus, a limited thoracotomy was performed via the submammary incision, and the large patch was placed epicardially. The mean R wave amplitude was 12 ± 3 mV, the mean pacing threshold was 1.0 ± 0.5 V at 0.5 msec, and the mean defibrillation threshold was 12.6 ± 3 J. ICD generators implanted were the Ventak-P in 17, PCD-7217 in 5, and the Cadence V-l00 in 6 patients. These patients have been followed for a mean of 14.6 ± 6 months. There was no perioperative mortality, and none of the patients developed an infection during follow-up. Generator migration or significant discomfort requiring ICD repositioning was not observed, although one patient developed an erosion requiring surgical repair.Conclusions: Subpectoral implantation of the ICD generator is feasible and was well tolerated by all patients with an acceptable complication rate (3.5%). As the size of future generation ICDs is reduced, subpectoral implantation may become the preferred approach. 相似文献
87.
88.
Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells 总被引:4,自引:0,他引:4
Chekhun VF Kulik GI Yurchenko OV Tryndyak VP Todor IN Luniv LS Tregubova NA Pryzimirska TV Montgomery B Rusetskaya NV Pogribny IP 《Cancer letters》2006,231(1):87-93
The resistance of cancer cells to chemotherapeutic agents is a major clinical problem and an important cause of treatment failure in cancer. Mechanisms that have developed to guard cancer cells against anti-cancer drugs are major barriers to successful anti-cancer therapy. Therefore, the identification of novel mechanisms of cellular resistance holds the promise of leading to better treatments for cancer patients. In the present study, we used human MCF-7 breast adenocarcinoma cell line and its doxorubicin-resistant variant MCF-7/R to determine the role of alterations of DNA methylation of chemoresitance-related genes, such as multidrug resistance 1 (MDR1), glutathione-S-transferase (GSTpi), O(6)-methylguanine DNA methyltransferase (MGMT), and urokinase (Upa), in the development of drug resistance. The promoter regions of MDR1, GSTpi, MGMT, and Upa genes were highly methylated in MCF-7 cell line but not in its MCF-7/R drug resistant variant. The hypomethylated status of MDR1 gene was associated with overexpression of P-glycoprotein. We hypothesize that acquirement of doxorubicin resistance of MCF-7 cells is associated with DNA hypomethylation of the promoter regions of the MDR1, GSTpi, MGMT, and Upa genes. 相似文献
89.
Cancer cells are characterized by epigenetic dysregulation, including global genome hypomethylation, regional hypo- and hypermethylation, altered histone modifications, and disturbed genomic imprinting. Despite the long-established fact that global DNA hypomethylation is a common feature of tumors, very little is known about evolution of this and other epigenetic alterations during tumor progression. The present study was undertaken to characterize the status of epigenetic dysregulation in three human breast cancer cell lines (MCF-7, MDA-MB-231 and MDA-MB-231(S30) that represent different stages of human breast cancer. Our data show that breast cancer cells are characterized by significant alterations in cellular epigenetic status compared to non- tumorigenic MCF-10-2A epithelial breast cells. Interestingly, more malignant MDA-MB- 231 human breast cancer cells have a more prominent loss of DNA methylation accompanied by altered expression of maintenance DNA methyltransferase DNMT1, methyl-binding proteins MeCP2 and MBD2, decreased trimethylation of lysine 20 of histone H4 and hyperacetylation of histone H4 compared to MCF-7 cells. The decrease in trimethylation of lysine 20 of histone H4 in MDA-MB-231 cells was accompanied by diminished expression of Suv4-20h2 histone methyltransferase. The results of present study demonstrate that MDA-MB-231 cells have more extensive epigenenic alterations than MCF-7. These results demonstrate that human breast cancer cells are characterized by prominent epigenetic alterations which are associated with increased malignant properties of cancer cells. Such epigenetic dysregulation may contribute to and may be indicative of the formation of a more aggressive tumor phenotype during tumor progression. 相似文献
90.
Linkage analysis of candidate regions for coeliac disease genes 总被引:5,自引:0,他引:5
Houlston RS; Tomlinson IP; Ford D; Seal S; Marossy AM; Ferguson A; Holmes GK; Hosie KB; Howdle PD; Jewell DP; Godkin A; Kerr GD; Kumar P; Logan RF; Love AH; Johnston S; Marsh MN; Mitton S; O'Donoghue D; Roberts A; Walker-Smith JA; Stratton MF 《Human molecular genetics》1997,6(8):1335-1339
A strong HLA association is seen in coeliac disease [specifically to the
DQ(alpha1*0501,beta1*0201 heterodimer], but this cannot entirely account
for the increased risk seen in relatives of affected cases. One or more
genes at HLA-unlinked loci also predispose to coeliac disease and are
probably stronger determinants of disease susceptibility than HLA. A recent
study has proposed a number of candidate regions on chromosomes 6p23
(distinct from HLA), 6p12, 3q27, 5q33.3, 7q31.3, 11p11, 15q26, 19p13.3,
19q13.1, 19q13.4 and 22cen for the location of a non-HLA linked
susceptibility gene. We have examined these regions in 28 coeliac disease
families by linkage analysis. There was excess sharing of chromosome 6p
markers, but no support for a predisposition locus telomeric to HLA. No
significant evidence in favour of linkage to coeliac disease was obtained
for chromosomes 3q27, 5q33.3, 7q31.3, 11p11, 19p13.3, 19q13.1, 19q13.4 or
22cen. There was, however, excess sharing close to D15S642. The maximum
non-parametric linkage score was 1.99 (P = 0.03). Although the evidence for
linkage of coeliac disease to chromosome 15q26 is not strong, the well
established association between coeliac disease and insulin dependent
diabetes mellitus, together with the mapping of an IDDM susceptibility
locus (IDDM3) to chromosome 15q26, provide indirect support for this as a
candidate locus conferring susceptibility to coeliac disease in some
families.
相似文献